Drug news
NICE recommends Eliquis (BMS/Pfizer) for Venous Thromboembolism Prevention
The National Institute for Clinical Excellence (NICE) has published final draft guidance recommending Eliquis (apixaban) from BMS/Pfizer as an option for the prevention of venous thromboembolism (VTE) in adults who have undergone planned total hip replacement or total knee replacement surgery/